Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2008
12/23/2008US7468442 Process for the preparation of carvedilol form-II
12/23/2008US7468387 Crystalline forms of imidoalkanpercarboxylic acids
12/23/2008US7468177 Hydrophilic light absorbing compositions for determination of physiological function in critically ill patients
12/23/2008CA2492096C Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
12/18/2008WO2008154353A1 Thalidomide analogs for treating vascular abnormalities
12/18/2008WO2008153595A1 A novel photochromic article and a process for making a novel photochromic article
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor
12/18/2008WO2008152013A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/18/2008WO2008131000A3 7-substituted indole mcl-1 inhibitors
12/18/2008US20080312462 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives
12/18/2008US20080312454 e.g.N,N',N''-triphenyl-N,N',N''-tris(9-phenylcarbazol-3-yl)-benzene-1,3,5-triamine; high glass transition point and excellent heat resistance
12/18/2008US20080312453 Novel Carbazole Compound, and Polymer Thereof
12/18/2008US20080312308 Substituted acetic acid derivatives
12/18/2008US20080312307 Mapk/erk kinase inhibitors
12/18/2008US20080312270 Compounds and methods useful for treating asthma and allergic inflammation
12/18/2008US20080312237 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
12/18/2008US20080311495 Photochromic material, inkless reimageable printing paper, and methods
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2690569A1 Indolinone derivatives and their use in treating disease-states such as cancer
12/17/2008EP2003142A1 Amorphous perindopril erbumine
12/17/2008EP2003119A1 Substituted acetamides as modulators of EP2 receptors
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2001847A2 Soluble adenylate cyclase inhibitors
12/17/2008EP2001846A1 Indole derivatives as inhibitors of the soluble adenylate cyclase
12/17/2008EP2001845A2 Synthesis of thrombopoietin activity modulating compounds
12/17/2008EP2001844A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/17/2008EP2001843A2 Soluble adenylate cyclase inhibitors
12/17/2008EP1638937B1 Fluvastatin sodium crystal form xiv, processes for preparing it, compositions containing it and methods of using it
12/17/2008CN101326165A M-carbazolylphenyl compounds
12/17/2008CN101326164A Inhibitors of CCR9 activity
12/17/2008CN101326151A Improved method for the production of ramipril
12/17/2008CN101323587A Novel carbazole compound, and polymer thereof
12/17/2008CN101323586A Synthetic process of L-5-hydroxy ª‰-indole alanine
12/17/2008CN101323585A Enrichment and purification method of benzene acryloyl 5-hydroxytryptamine compound in safflower seed
12/17/2008CN101323580A Synthetic methods of chiral aryloxy propanol amine compounds and salts thereof
12/17/2008CN100443486C 7-esterified and 7,20-double esterified camptothecine derivant and method for preparing the same and pharmaceutical combination and uses thereof
12/17/2008CN100443480C Tricyclic compound and its preparation and use
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465811 [3-[[[[2,3-dihydro-1-[[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]sulfonyl]-1H-indol-2-yl]carbonyl]amino]methyl]phenoxy]acetic acid methyl ester; retinoic acid, farnesoid X, peroxisome proliferator-activated receptors modulator; antiinflammatory, antidiabetic agent, atherosclerosis, Alzheimer's disease
12/16/2008US7465810 Reactive 1,3′-crosslinked carbocyanine
12/16/2008US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
12/16/2008CA2335959C Colorants
12/11/2008WO2008149181A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/11/2008WO2008149154A2 Tegaserod succinate and polymorphic forms
12/11/2008WO2008149140A2 Tegaserod oxalate and polymorphic forms
12/11/2008WO2008149139A2 Tegaserod fumarate and polymorphic forms
12/11/2008WO2008149138A1 Tegaserod malate and polymorphic forms
12/11/2008WO2008149137A2 Tegazerod benzoate and polymorphic forms
12/11/2008WO2008149136A1 Tegaserod besylate and polymorphic forms
12/11/2008WO2008148755A2 Novel 5-substituted hydantoins
12/11/2008WO2008148279A1 Cyclobutyl-fused pyrrolidine derivatives, their preparation methods and their medical use
12/11/2008US20080306281 Novel compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of alpha-perfluoroalkylamine compounds
12/11/2008US20080306259 Hydroxylation of beta-dicarbonyls with zirconium catalysts
12/11/2008US20080306258 Cyclopropane compounds and pharmaceutical use thereof
12/11/2008US20080306135 Process for the Preparation of Crystalline Perindopril
12/11/2008US20080306134 Thalidomide analogs for treating vascular abnormalities
12/11/2008US20080306131 Progesterone receptor modulator and uses thereof
12/11/2008US20080306129 Benzimidazoles useful as modulators of ion channels
12/11/2008US20080306041 Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
12/11/2008US20080305955 Spiroketal-Substituted Cyclic Ketoenols
12/11/2008US20080305048 Self-Assembling Nanoparticle Conjugates
12/11/2008US20080303433 Fluorene-based derivative and organic electroluminescence device employing the same
12/11/2008CA2691446A1 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
12/10/2008EP1999165A1 Transition metal complex, catalyst composition including the same and olefin polymer using catalyst composition
12/10/2008EP1998766A2 Useful indole compounds
12/10/2008EP1856035B1 Process for preparaing protected amiidines
12/10/2008EP1706113B1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride
12/10/2008EP1404317B1 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors
12/10/2008CN101321749A Novel vinylogous acids derivatives
12/10/2008CN101321728A Diaminoarylene compound having carbazolyl group and use thereof
12/10/2008CN101321727A 肟酯光敏引发剂 Oxime ester photoinitiator
12/10/2008CN101321726A Novel fused pyrrole derivative
12/10/2008CN101318926A Soluble functional carbazole derivant, preparation method and application thereof
12/10/2008CN101318925A Pyrrolidine-tetratomic ring derivants, preparation method and medical uses thereof
12/10/2008CN101318924A 5-alkyl substitution indole derivant and preparation method thereof
12/10/2008CN100441574C Tricyclic compounds, their production and use
12/10/2008CN100441570C Preparation of mitiglinide calcium and its quality control method
12/09/2008US7462716 Statin derivatives
12/09/2008US7462640 e.g. 5-Chloro-3-methyl-N-[1-[2-(pyrrolidin-1-yl)ethyl-1H-indol-6-yl]-benzo[b]thiophene-2-sulfonamide; serotonin receptor modulator; anxiolytic agent, antidepressant; nervous and gastrointestinal disorders, antidiabetic agent; bipolar disorders, cognitive memory disorders, neurodegenerative disorders
12/09/2008US7462629 Therapy or prevention diseases caused by lymphocyte interaction; antiinflammatory agents; autoimmune disease
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462347 cyanine dyes and/or with lipophilic side chains; to detect stained cells both in vivo and in vitro; increased signal to noise ratio for rapidly labeling; improved solubility
12/09/2008CA2453946C Process for the preparation of 3-spiro[cyclohexam-1,3'-[3h]indolin-2'-one] derivatives
12/09/2008CA2415447C Novel .gamma. crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
12/09/2008CA2379061C Antibacterial agents
12/09/2008CA2249958C Binuclear iridium(i) phosphine complexes and their use as catalyst in the asymmetric hydroamination of olefins
12/04/2008WO2008148034A1 Mapk/erk kinase inhibitors
12/04/2008WO2008147246A1 Catalyst for dehydrogenation of 4,5,6,7 tetrahydroindole into indole and method for preparing thereof
12/04/2008WO2008146838A1 Organic electroluminescent device, display device and illuminating device
12/04/2008WO2008145616A1 Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
12/04/2008US20080300348 Polymer
12/04/2008US20080300291 Potent indole-3-carbinol-derived antitumor agents
12/04/2008US20080300271 Novel compounds and a novel process for their preparation
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080300240 Pde10 inhibitors and related compositions and methods
12/04/2008US20080297034 Biphenyl derivative and organic light-emitting element using same
12/04/2008CA2687132A1 4' substituted compounds having 5-ht6 receptor affinity
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 458